Business
KORU Medical Expands Senior Team to Accelerate Growth Strategy
CHESTER, N.Y.--(BUSINESS WIRE)-- Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical
About this update from Koru Medical Systems, Inc.
[{"type":"text","content":" CHESTER, N.Y.--(BUSINESS WIRE)--\nRepro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (\"KORU Medical\" or the \"Company\"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced the appointment of two new leaders who will be responsible for key elements of the Company's growth strategy: Rob Cannon as the Company's new Vice President of Sales, and Brian Hertzog as the Company's new Vice President of BioPharma Business Development. Mr. Cannon will be responsible for U.S. sales and increasing the overall penetration of subcutaneous therapy for commercialized biopharmaceutical drugs. Mr. Hertzog will be responsible for leading biopharmaceutical business development and increasing the number of new biopharmaceutical drugs on the Freedom platform.\n\n\"KORU Medical provides the market-leading device in the specialty pharmacy channel for infusing subcutaneous immunoglobulins. Our quality, reliability, and value-added support has facilitated safe and effective infusions for tens of thousands of patients,\" said Linda Tharby, Chief Executive Officer. \"Rob will lead our U.S. sales team to accelerate growth in our domestic core business. He brings deep expertise in specialty pharmacy, alternate site, and the plasma and biologics industry.\"\n\nMs. Tharby continued, \"There is a significant unmet need for large-volume subcutaneous infusion solutions in biopharmaceuticals, both in drugs for clinical studies and commercial use. KORU Medical brings this expertise with FDA/CE mark regulatory clearance and millions of safe home infusions delivered every year. Brian will lead the development of new biopharmaceutical relationships for our novel therapies business, building upon his track record of growing innovative parenteral injection technologies, drug containers, and medication closure systems.\"\n\n\"Not only do Rob and Brian add impressive capabilities to the KORU Medical team, but our ability to attract top-tier talent demonstrates the growth potential of our business,\" finished Ms. Tharby.\n\nRob Cannon brings over 30 years of experience in sales across the healthcare industry. For the past 11 years, Mr. Cannon has been with McKesson, a healthcare supply chain management company specializing in providing pharmaceuticals and healthcare services ...